INTS

NASDAQ · Equity

Intensity Therapeutics, Inc. Common stock

US Healthcare Biotechnology

Latest week
29 May 2026
Close
4.390000
Fair value
65.515378
Expectation
Negative 40.72%
Weekly Close Trend Line Fair Value Activity Lines

Chart Summary

Key Points

Week Ending
29 May 2026
Latest Close
4.39
12-Week Change
-35.25%
Trend Signal
Inactive
Expectation
Negative 40.72%
Signal Weeks
0 of 12
Vs Trend Line
Below
Vs Fair Value
Below
Relative Strength
-54.83
Market Dynamics
-0.23

Over the latest 12 completed weeks ending 2026-05-29, INTS fell 35.25%, moving from 6.78 to 4.39. The latest weekly close is below the Trend Line and below Fair Value. Trend Signal is inactive on the latest week and was active in 0 of the last 12 weeks. Relative Strength is -54.83 and has softened across the 12-week window. Market Dynamics is -0.23 on the latest week. Expectation is negative at 40.72%.